concept

CSF

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CSF: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

133Connections

22Hypotheses

6Analyses

50Outgoing

50Incoming

1Experiments

7Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	CSF
Key Genes/Proteins	ACSL4, ADAM10, AMYLOID, AMYLOID-BETA, APOE, APP
Related Diseases	AGING, ALS, ALZHEIMER, ALZHEIMER'S DISEASE
Related Pathways	AMPK SIGNALING
Linked Hypotheses	22 hypotheses

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Pathway Diagram

graph TD
    CSF[CSF]
    CSF -->|involved_in| Glymphatic_Pathway[Glymphatic Pathway]
    CSF -->|contains| PD_ProS[PD_ProS]
    CSF -->|activates| AQP4[AQP4]
    CSF -->|inhibits| MELANOMA[MELANOMA]
    CSF -->|regulates| TAU[TAU]
    CSF -->|interacts| SYK[SYK]
    CSF -->|interacts| ALZHEIMER_S_DISEASE[ALZHEIMER'S DISEASE]
    CSF -->|phosphorylates| NEURODEGENERATION[NEURODEGENERATION]
    Cryptic_Hdgfl2[Cryptic Hdgfl2] -->|expressed in| CSF
    TAU -->|expressed in| CSF
    OSTEOCLASTS[OSTEOCLASTS] -->|regulates| CSF
    NGF[NGF] -->|interacts| CSF
    MACROPHAGE[MACROPHAGE] -->|activates| CSF
    neurodegeneration[neurodegeneration] -->|regulates| CSF
    AQP4 -->|loss_affects| CSF
    APOE[APOE] -->|produces| CSF

Outgoing (58)

Target	Relation	Type	Str
h-var-c261b9d0cd	targeted_by	hypothesis	1.00
h-cef0dd34	targeted_by	hypothesis	1.00
h-var-3049fa9ae4	targeted_by	hypothesis	1.00
Glymphatic Pathway	involved_in	pathway	0.90
PD_ProS	contains	phenotype	0.72
SYK	interacts_with	gene	0.65
SYK	activates	gene	0.65
AQP4	activates	gene	0.65
MELANOMA	inhibits	disease	0.65
TAU	regulates	protein	0.65
ALZHEIMER	phosphorylates	disease	0.65
PARKINSON'S DISEASE	biomarker_for	disease	0.65
NEURODEGENERATION	phosphorylates	phenotype	0.65
MICROGLIA	regulates	cell_type	0.65
MICROGLIAL ACTIVATION	interacts_with	phenotype	0.65
ALZHEIMER	biomarker_for	disease	0.65
NEURODEGENERATION	exacerbates	phenotype	0.65
ALZHEIMER'S DISEASE	interacts_with	disease	0.65
PROTEOME	contains	pathway	0.64
TAU	phosphorylates	protein	0.60
APOE	treats	gene	0.60
APP	exacerbates	gene	0.60
TAU	targets	protein	0.60
NEUROFILAMENT LIGHT	synergizes_with	biomarker	0.60
NEUROFILAMENT LIGHT	regulates	biomarker	0.60
ATM	activates	gene	0.60
TAU	causes	protein	0.60
TAU	inhibits	protein	0.60
KDM6A	stabilizes	gene	0.60
BDNF	stabilizes	gene	0.60
BDNF	protects_against	gene	0.60
BDNF	activates	gene	0.60
JNK	activates	gene	0.60
TAU	stabilizes	protein	0.60
TDP-43	phosphorylates	gene	0.60
TDP-43	stabilizes	gene	0.60
AMYLOID	inhibits	protein	0.60
AMYLOID	targets	protein	0.60
NEURODEGENERATION	targets	phenotype	0.60
PRION	phosphorylates	protein	0.60
MICROGLIAL ACTIVATION	stabilizes	phenotype	0.60
MICROGLIAL ACTIVATION	treats	phenotype	0.60
HISTONE ACETYLATION	inhibits	phenotype	0.60
AGING	biomarker_for	phenotype	0.60
P-TAU	associated_with	protein	0.60
AGING	destabilizes	phenotype	0.60
NEURODEGENERATION	interacts_with	phenotype	0.60
ALS	treats	disease	0.60
AUTOPHAGY	activates	phenotype	0.60
AMYLOID	activates	protein	0.60

Incoming (75)

Source	Relation	Type	Str
h-var-3049fa9ae4	targets	hypothesis	1.00
h-var-c261b9d0cd	targets	hypothesis	1.00
h-cef0dd34	targets	hypothesis	1.00
Cryptic Hdgfl2	expressed_in	biomarker	0.92
gaps-csf-cytokine-profiles-pd-biomarkers	describes	wiki	0.90
biomarkers-cbs-psp-csf-biomarkers	describes	wiki	0.90
biomarkers-csf-biomarker-comparison	describes	wiki	0.90
biomarkers-csf-neurofilament-light	describes	wiki	0.90
biomarkers-csf-o-glcnac	describes	wiki	0.90
biomarkers-csf-pta181	describes	wiki	0.90
biomarkers-csf-synaptic-biomarker-panel	describes	wiki	0.90
biomarkers-14-3-3-proteins-csf	describes	wiki	0.90
TAU	expressed_in	protein	0.72
TAU	interacts_with	protein	0.65
OSTEOCLASTS	regulates	cell_type	0.65
NGF	interacts_with	gene	0.65
TAU	treats	protein	0.65
MACROPHAGE	activates	cell_type	0.65
neurodegeneration	regulates	phenotype	0.64
COGNITIVE DECLINE	inhibits	phenotype	0.60
ROS	stabilizes	phenotype	0.60
ALS	causes	disease	0.60
ALS	stabilizes	disease	0.60
COGNITIVE DECLINE	stabilizes	phenotype	0.60
ALS	regulates	disease	0.60
MELATONIN	stabilizes	drug	0.60
ASTROCYTE	activates	cell_type	0.60
AMYLOID-BETA	produces	protein	0.60
ROS	targets	phenotype	0.60
AQP4	loss_affects	entity	0.60
CHOROID PLEXUS	activates	cell_type	0.60
APOE	produces	gene	0.60
ADAM10	produces	gene	0.60
SNAP25	inhibits	gene	0.60
TREM2	stabilizes	gene	0.60
LRRK2	expressed_in	gene	0.55
BRAF	expressed_in	gene	0.55
MONOCYTES	expressed_in	cell_type	0.55
HIPPOCAMPUS	associated_with	brain_region	0.50
QUERCETIN	associated_with	drug	0.50
LITHIUM	associated_with	drug	0.50
CORPUS CALLOSUM	associated_with	brain_region	0.50
NICOTINAMIDE	associated_with	drug	0.50
ROS	associated_with	phenotype	0.50
ADUCANUMAB	associated_with	drug	0.50
LECANEMAB	associated_with	drug	0.50
GRAY MATTER	associated_with	brain_region	0.50
MELATONIN	associated_with	drug	0.50
TREHALOSE	associated_with	drug	0.50
METFORMIN	associated_with	drug	0.50

Targeting Hypotheses (22)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
CSF1R Inhibition-Mediated Microglial Replacement as a State	0.898	neurodegeneration	How do different microglial subtypes (DA
CSF1R-TREM2 Co-Agonism for Sustained Microglial Expansion	0.808	neurodegeneration	TREM2 agonism vs antagonism in DAM micro
CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Wind	0.801	neuroimmunology	TREM2 in Alzheimer's Disease: Mechanisms
TREM2-CSF1R Cross-Talk in Microglial Metabolic Reprogramming	0.748	neurodegeneration	Gene expression changes in aging mouse b
Integrated Multi-Analyte CSF Panel Combining YKL-40, sTREM2,	0.730	biomarkers	What biomarkers can reliably detect micr

CSF YKL-40 as a Priming-Specific Chitinase Marker	0.710	biomarkers	What biomarkers can reliably detect micr
CSF Soluble TREM2 Fragment Ratio as Priming State Indicator	0.680	biomarkers	What biomarkers can reliably detect micr
Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio	0.665	translational neuroscience	Which metabolic biomarkers can distingui
CSF Biomarker-Guided ABCA7 Therapeutic Dosing	0.619	neurodegeneration	Why does the V1613M variant reduce amylo
CSF ApoE- and clusterin-rich lipoprotein particles stabilize	0.606	neurodegeneration	Which specific CSF molecular components
Temporal Decoupling of CSF p-tau217 Normalization from Amylo	0.595	neurodegeneration	-
CSF p-tau217 Normalization Reflects Amyloid-Driven Tau Patho	0.586	neurodegeneration	-
Ganglioside-rich extracellular vesicles preserve alpha-synuc	0.582	neurodegeneration	Which specific CSF molecular components
CSF1R Partial Agonism Combined with TREM2 Activation for ALS	0.535	neurodegeneration	Microglial subtypes in neurodegeneration
CSF p-tau217 Normalization Requires Intact Synaptic Function	0.515	neurodegeneration	-
CSF p-tau217 Threshold of <0.15 pg/mL Predicts Durable Clini	0.512	neurodegeneration	-
TREM2 on Perivascular Macrophages Senses Aβ and Drives SPP1	0.496	neurodegeneration	How do perivascular cells specifically r
Sulfated glycans and metal-binding CSF proteins brace alpha-	0.489	neurodegeneration	Which specific CSF molecular components
CSF Neurofilament Light Chain-Guided Astrocyte-Derived Extra	0.461	molecular neurobiology	View
CSF Neurofilament Light-Triggered Astrocyte-Derived Exosome	0.460	molecular neurobiology	View
CSF1R Inhibition Reversal Window Depends on Microglia Replac	0.395	neurodegeneration	What is the optimal therapeutic window f
GrimAge Acceleration as a Cell-Type-Resolved CSF Biomarker P	0.351	-	Epigenetic clocks as biomarkers for Alzh

Mentioning Analyses (6)

Scientific analyses that reference this entity

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

neurodegeneration | 2026-04-26 | 5 hypotheses Top: 0.712

Which specific CSF molecular components are essential for maintaining disease-re

neurodegeneration | 2026-04-25 | 3 hypotheses Top: 0.606

Proteomics Differential Expression in AD CSF and Brain Tissue

neurodegeneration | 2026-04-16 | 0 hypotheses

Metabolomic signatures of neurodegeneration: metabolic reprogramming in aging br

metabolomics | 2026-04-16 | 7 hypotheses Top: 0.520

Neuroinflammation and microglial priming in early Alzheimer's Disease

neurodegeneration | 2026-04-04 | 0 hypotheses

Experiments (1)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Autophagy receptor identification for stress granule elimination	exploratory	neurodegenerative diseases	0.900	0.00	cultured cells under arsenite	proposed	N/A

Related Papers (12)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Dynamics and Impact of Repopulating Microglia Following Oligodendroglial Damage. [PMID:41645884]	Di Pietro AA, Thomas L, Pasquini LA	J Neurochem	2026
Temporal modulation of microglial repopulation attenuates retinal degeneration i [PMID:41690604]	Zhang W, Bian B, Ren C	Neurobiol Dis	2026
The impact of CSF1R inhibitor-mediated microglial depletion in rodent models of [PMID:41822299]	Ferreira AFF, Santos-Silva AC, Muratori	Front Aging Neurosci	2026
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025
Neurodegeneration and demyelination in multiple sclerosis. [PMID:38889714]	Garton T, Gadani SP, Gill AJ, Calabresi	Neuron	2024
STING orchestrates the neuronal inflammatory stress response in multiple scleros [PMID:38878778]	Woo MS, Mayer C, Binkle-Ladisch L, Sonne	Cell	2024
Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration. [PMID:36917977]	Neel DV, Basu H, Gunner G, Bergstresser	Neuron	2023
CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model w [PMID:34103079]	["Lodder Chritica", "Scheyltjens Isabell	Acta neuropathologica communic	2021
Don't know what you got till it's gone: microglial depletion and neurodegenerati [PMID:33642360]	["Graykowski David", "Cudaback Eiron"]	Neural regeneration research	2021
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020
Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental T [PMID:32094203]	["Henry Rebecca J", "Ritzel Rodney M", "	The Journal of neuroscience :	2020
Multiple Sclerosis Pathology. [PMID:29358320]	Lassmann H	Cold Spring Harbor perspective	2018

Debates (7)

Multi-agent debates referencing this entity

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

active · Rounds: 7 · Score: 0.00 · 2026-04-26

Which specific CSF molecular components are essential for maintaining disease-re

active · Rounds: 4 · Score: 0.66 · 2026-04-25

Which proteins are differentially expressed in AD CSF and brain tissue, and do t

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

What are the key metabolic alterations detectable in brain tissue, CSF, and bloo

closed · Rounds: 4 · Score: 0.50 · 2026-04-18

Is a 12-protein CSF panel superior to existing plasma p-tau217 for clinical AD p

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Neuroinflammation and microglial priming in early Alzheimer's Disease

closed · Rounds: 2 · Score: 0.95 · 2026-04-04

Extracellular vesicle biomarkers for early AD detection

closed · Rounds: 4 · Score: 0.87 · 2026-04-02

Related Research

Hypotheses and analyses mentioning CSF in their description or question text

CSF YKL-40 as a Priming-Specific Chitinase Marker

Score: 0.710 · biomarkers · 2026-04-22

## Mechanistic Overview CSF YKL-40 as a Priming-Specific Chitinase Marker starts from the claim that modulating CHI3L1/Y

CSF Soluble TREM2 Fragment Ratio as Priming State Indicator

Score: 0.680 · biomarkers · 2026-04-22

## Mechanistic Overview CSF Soluble TREM2 Fragment Ratio as Priming State Indicator starts from the claim that modulatin

Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interfa

Score: 0.665 · translational neuroscience · 2026-04-12

## Mechanistic Overview Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interface Biomarker sta

CSF Biomarker-Guided ABCA7 Therapeutic Dosing

Score: 0.619 · neurodegeneration · 2026-04-14

## **Molecular Mechanism and Rationale** ABCA7 (ATP-binding cassette transporter A7) functions as a critical lipid effl

CSF ApoE- and clusterin-rich lipoprotein particles stabilize disease-relevant al

Score: 0.606 · neurodegeneration · 2026-04-25

Specific lipoprotein particles bind fibril surfaces and preserve polymorph architecture and seeding fidelity outside the

Ganglioside-rich extracellular vesicles preserve alpha-synuclein fibril conforma

Score: 0.582 · neurodegeneration · 2026-04-25

Membrane-derived cofactors in extracellular vesicles maintain polymorph fidelity and templating competence.

CSF1R Partial Agonism Combined with TREM2 Activation for ALS Neuroprotection

Score: 0.535 · neurodegeneration · 2026-04-25

Premature investment. The Expert identifies that no validated partial CSF1R agonist exists—creating partial agonism for

TREM2 on Perivascular Macrophages Senses Aβ and Drives SPP1 Upregulation Through

Score: 0.496 · neurodegeneration · 2026-04-22

## Mechanistic Overview TREM2 on Perivascular Macrophages Senses Aβ and Drives SPP1 Upregulation Through CSF1R-Mediated

Sulfated glycans and metal-binding CSF proteins brace alpha-synuclein fibril pol

Score: 0.489 · neurodegeneration · 2026-04-25

Electrostatic bridging by glycans and low-abundance proteins preserves disease-relevant fibril architecture.

CSF Neurofilament Light Chain-Guided Astrocyte-Derived Extracellular Vesicle Del

Score: 0.461 · molecular neurobiology · 2026-04-21

## Mechanistic Overview CSF Neurofilament Light Chain-Guided Astrocyte-Derived Extracellular Vesicle Delivery of lncRNA-

CSF Neurofilament Light-Triggered Astrocyte-Derived Exosome Dosing Maximizes lnc

Score: 0.460 · molecular neurobiology · 2026-04-21

## Mechanistic Overview CSF Neurofilament Light-Triggered Astrocyte-Derived Exosome Dosing Maximizes lncRNA-0021 Therape

CSF

Understanding Entity Pages

Wiki Pages (21)

CSF Neurofilament Light Chain (NfL) in Neurodegeneration

Cerebrospinal Fluid (CSF) Biomarkers Overview

Cerebrospinal Fluid (CSF) Biomarkers in Neurodegeneration

CSF1R Inhibitors for Parkinson's Disease

CSF-1R Inhibitors

NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease Progression

Microglial Proteins in CSF Reveal AD Progression States

CSF Biomarkers for Corticobasal Syndrome and Progressive Supranuclear Palsy

Glymphatic and CSF Dynamics Enhancement for CBS/PSP

CSF Dynamics and Glymphatic Therapy in CBS/PSP

CSF1R-Targeted Microglia Therapy

GM-CSF Sargramostim Phase 2 (NCT04902703) - AD Immunotherapy

Pexidartinib (PLX3397) CSF1R Inhibitor Parkinson's Disease Trial (NCT04888966)

CSF1R Modulation Therapy: Microglia Reset Protocol

Bruce L. Miller — Director of UCSF Memory and Aging Center

CSF1R Inhibitors for Neurodegeneration

CSF2RA — Colony Stimulating Factor 2 Receptor Alpha Chain

CSF O-GlcNAc — Target Engagement Biomarker for OGA Inhibitors

GM-CSF Receptor Alpha Chain

GM-CSF Receptor Common Beta Chain

Section 126: Glymphatic System and CSF Dynamics in CBS/PSP

Pathway Diagram

Outgoing (58)

Incoming (75)

Targeting Hypotheses (22)

Mentioning Analyses (6)

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

Which specific CSF molecular components are essential for maintaining disease-re

Proteomics Differential Expression in AD CSF and Brain Tissue

Metabolomic signatures of neurodegeneration: metabolic reprogramming in aging br

Neuroinflammation and microglial priming in early Alzheimer's Disease

Extracellular vesicle biomarkers for early AD detection

Experiments (1)

Related Papers (12)

Debates (7)

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

Which specific CSF molecular components are essential for maintaining disease-re

Which proteins are differentially expressed in AD CSF and brain tissue, and do t

What are the key metabolic alterations detectable in brain tissue, CSF, and bloo

Is a 12-protein CSF panel superior to existing plasma p-tau217 for clinical AD p

Neuroinflammation and microglial priming in early Alzheimer's Disease

Extracellular vesicle biomarkers for early AD detection

Related Research

CSF YKL-40 as a Priming-Specific Chitinase Marker

CSF Soluble TREM2 Fragment Ratio as Priming State Indicator

Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammation-Metabolism Interfa

CSF Biomarker-Guided ABCA7 Therapeutic Dosing

CSF ApoE- and clusterin-rich lipoprotein particles stabilize disease-relevant al

Ganglioside-rich extracellular vesicles preserve alpha-synuclein fibril conforma

CSF1R Partial Agonism Combined with TREM2 Activation for ALS Neuroprotection

TREM2 on Perivascular Macrophages Senses Aβ and Drives SPP1 Upregulation Through

Sulfated glycans and metal-binding CSF proteins brace alpha-synuclein fibril pol

CSF Neurofilament Light Chain-Guided Astrocyte-Derived Extracellular Vesicle Del

CSF Neurofilament Light-Triggered Astrocyte-Derived Exosome Dosing Maximizes lnc